>Pharming already received an orphan designation [for HAE] more than a year ago.<
I do not understand your point. Orphan-drug marketing exclusivity goes to the first drug to be approved, not the first drug to receive an orphan designation.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.